A RUDN University chemist has synthesized new derivatives of 1,2,4-triazole that exhibit antidiabetic properties. Experiments showed that these compounds work better than acarbose, a widely used hypoglycemic drug, and demonstrate antioxidant properties. In the future, they can be used to develop drugs against type 2 diabetes. The article is published in the journal Bioorganic Chemistry.